Clinical Trials in Cleveland

Showing 4921-4940 of 19,775 trials

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

NCT02860130

The purpose of this research is to determine if an investigational new drug solution called Prismocitrate 18 lengthens extracorporeal circuit life in patients treated with continuous renal replacement therapy (CRRT). Patients who receive CRRT treatment with Prismocitrate 18 as the anticoagulant will be compared to patients who receive CRRT treatment with no anticoagulation.

Regional Citrate Anticoagulation (RCA)Continuous Renal Replacement Therapy (CRRT)Acute Kidney Injury

Vantive Health LLC34 participantsStarted Sep 2016

Birmingham, Alabama, United States • Tucson, Arizona, United States • New Haven, Connecticut, United States +9 more locations

COMPLETEDPhase 1/2< 1 mile

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

NCT04381832

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of etrumadenant (AB928)-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

Prostatic Neoplasms, Castration-ResistantAndrogen-Resistant Prostatic NeoplasmsCastration Resistant Prostatic Neoplasms+1 more

Arcus Biosciences, Inc.173 participantsStarted Jul 2020

Cerritos, California, United States • Encino, California, United States • Orange, California, United States +16 more locations

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Find Trials by Condition in Cleveland

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Locating Biomarkers in OCD Through Behavioral Tasks

Evaluation of the Impact of Stress on IVF Outcome

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain

Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis

Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral Total Knee Arthroplasty (TKA)